COVID-19 vaccines: where we stand and challenges ahead

In the eleven months elapsed since the identification of the SARS-CoV-2 virus and its genome, an exceptional effort by the scientific community has led to the development of over 300 vaccine projects. Over 40 are now undergoing clinical evaluation, ten of these are in Phase III clinical trials, thre...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cell death and differentiation Jg. 28; H. 2; S. 626 - 639
Hauptverfasser:	Forni, Guido, Mantovani, Alberto
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Nature Publishing Group 01.02.2021
Schlagworte:	Bacillus Calmette-Guerin vaccine BCG Clinical trials COVID-19 COVID-19 - epidemiology COVID-19 - immunology COVID-19 - prevention & control COVID-19 vaccines COVID-19 Vaccines - immunology COVID-19 Vaccines - therapeutic use Genomes Humans Innate immunity Pandemics Pandemics - prevention & control SARS-CoV-2 - immunology Severe acute respiratory syndrome coronavirus 2 Vaccines
ISSN:	1350-9047, 1476-5403, 1476-5403
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!